{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:26:49Z","timestamp":1791293209354,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim Care Resp Med"],"DOI":"10.1038\/npjpcrm.2014.9","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T09:07:38Z","timestamp":1402564058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":476,"title":["Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey"],"prefix":"10.1038","volume":"24","author":[{"given":"David","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thys","family":"van der Molen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,12]]},"reference":[{"key":"BFnpjpcrm20149_CR1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095\u20132128.","journal-title":"Lancet"},{"key":"BFnpjpcrm20149_CR2","unstructured":"GINA Report, Global Strategy for Asthma Management and Prevention, 2012. http:\/\/www.ginasthma.org\/uploads\/users\/files\/GINA_Report_2011.pdf (accessed 18 June 2012)."},{"key":"BFnpjpcrm20149_CR3","unstructured":"The European Severe Asthma Survey, 2005. http:\/\/www.efanet.org\/wp-content\/documents\/SASSurveyFactSheet.pdf (accessed 6 March 2013)."},{"key":"BFnpjpcrm20149_CR4","unstructured":"Lung Health in Europe\u2014Facts and figures. Abbreviated version of the European Lung White Book, 2003. http:\/\/www.european-lung-foundation.org\/715-european-lung-foundation-elf-european-respiratory-society.htm (accessed March 2013)."},{"key":"BFnpjpcrm20149_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1183\/09059180.00008111","volume":"21","author":"P Demoly","year":"2012","unstructured":"Demoly P, Annunziata K, Gubba E, Adamek L . Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev 2012; 21: 66\u201374.","journal-title":"Eur Respir Rev"},{"key":"BFnpjpcrm20149_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1183\/09031936.00.16580200","volume":"16","author":"KF Rabe","year":"2000","unstructured":"Rabe KF, Vermeire PA, Soriano JB, Maier WC . Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802\u2013807.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm20149_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2466-6-13","volume":"6","author":"MR Partridge","year":"2006","unstructured":"Partridge MR, van der Molen T, Myrseth SE, Busse WW . Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006; 6: 13.","journal-title":"BMC Pulm Med"},{"key":"BFnpjpcrm20149_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1183\/09059180.00002110","volume":"19","author":"P Demoly","year":"2010","unstructured":"Demoly P, Gueron B, Annunziata K, Adamek L, Walters RD . Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev 2010; 19: 150\u2013157.","journal-title":"Eur Respir Rev"},{"key":"BFnpjpcrm20149_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4168\/aair.2011.3.4.217","volume":"3","author":"EJ Sims","year":"2011","unstructured":"Sims EJ, Price D, Haughney J, Ryan D, Thomas M . Current control and future risk in asthma management. Allergy Asthma Immunol Res 2011; 3: 217\u2013225.","journal-title":"Allergy Asthma Immunol Res"},{"key":"BFnpjpcrm20149_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1465-9921-12-38","volume":"12","author":"E Bateman","year":"2011","unstructured":"Bateman E, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M et al. Overall asthma control achieved with budesonide\/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Resh 2011; 12: 38.","journal-title":"Respir Resh"},{"key":"BFnpjpcrm20149_CR11","first-page":"A13","volume":"19","author":"D Price","year":"2010","unstructured":"Price D, Ali M, Burden A, Chisholm A, Lee AJ, Kemp L et al. Effectiveness of combination therapies: real-world versus randomized controlled trials. Prim Care Respir J 2010; 19: A13 (abstract 48).","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm20149_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4104\/pcrj.2009.00059","volume":"19","author":"S Pedersen","year":"2010","unstructured":"Pedersen S . From asthma severity to control: a shift in clinical practice. Prim Care Respir J 2010; 19: 3\u20139.","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm20149_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","volume":"170","author":"ED Bateman","year":"2004","unstructured":"Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170: 836\u2013844.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"BFnpjpcrm20149_CR14","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.rmed.2006.03.023","volume":"100","author":"L Bjermer","year":"2006","unstructured":"Bjermer L . Evidence-based recommendations or \u201cShow me the patients selected and I will tell you the results\u201d. Respir Med 2006; 100 (Suppl 1): S17\u2013S21.","journal-title":"Respir Med"},{"key":"BFnpjpcrm20149_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0895-4356(00)00305-X","volume":"54","author":"DA Braunholtz","year":"2001","unstructured":"Braunholtz DA, Edwards SJ, Lilford RJ . Are randomized clinical trials good for us (in the short term)? Evidence for a \"trial effect\". J Clin Epidemiol 2001; 54: 217\u2013224.","journal-title":"J Clin Epidemiol"},{"key":"BFnpjpcrm20149_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaci.2004.04.042","volume":"114","author":"KF Rabe","year":"2004","unstructured":"Rabe KF, Adachi M, Lai CK, Soriano JB, Vermiere PA, Weiss KB et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114: 40\u201347.","journal-title":"J Allergy Clin Immunol"},{"key":"BFnpjpcrm20149_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.pcrj.2005.04.003","volume":"14","author":"D Bellamy","year":"2005","unstructured":"Bellamy D, Harris T . Poor perceptions and expectations of asthma control: results of the International Control of Asthma Symptoms (ICAS) survey of patients and general practitioners. Prim Care Respir J 2005; 14: 252\u2013258.","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm20149_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4104\/pcrj.2011.00056","volume":"20","author":"MR Partridge","year":"2011","unstructured":"Partridge MR, Dal Negro RW, Olivieri D . Understanding patients with asthma and COPD: insights from a European study. Prim Care Respir J 2011; 20: 315\u2013323.","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm20149_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/rmed.2001.1241","volume":"96","author":"PA Vermeire","year":"2002","unstructured":"Vermeire PA, Rabe KF, Soriano JB, Maier WC . Asthma control and differences in management practices across seven European countries. Respir Med 2002; 96: 142\u2013149.","journal-title":"Respir Med"},{"key":"BFnpjpcrm20149_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pcrj.2003.11.007","volume":"13","author":"J Haughney","year":"2004","unstructured":"Haughney J, Barnes G, Partridge M, Cleland J . The Living & Breathing Study: a study of patients' views of asthma and its treatment. Prim Care Respir J 2004; 13: 28\u201335.","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm20149_CR21","unstructured":"iHARP: initiative Helping Asthma in Real-life Patients. http:\/\/iharp.org\/ (accessed 3 March 2013)."},{"key":"BFnpjpcrm20149_CR22","unstructured":"Fletcher M, Van der Molen T, Price D . Differences in Asthma Control and Management in Europe. European Respiratory Society Annual Congress. Oral presentation, Barcelona, Spain, 7\u201311 September 2013."},{"key":"BFnpjpcrm20149_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.rmed.2004.03.026","volume":"99","author":"K Herland","year":"2005","unstructured":"Herland K, Akselsen JP, Skjonsberg OH, Bjermer L . How representative are clinical study patients with asthma or COPD for a larger \"real life\" population of patients with obstructive lung disease? Respir Med 2005; 99: 11\u201319.","journal-title":"Respir Med"},{"key":"BFnpjpcrm20149_CR24","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.jaci.2007.09.019","volume":"120","author":"L Cazzoletti","year":"2007","unstructured":"Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 2007; 120: 1360\u20131367.","journal-title":"J Allergy Clin Immunol"},{"key":"BFnpjpcrm20149_CR25","unstructured":"Asthma Insight and Management in Europe and Canada (EUCAN AIM) survey, 2010. http:\/\/www.takingaimatasthma.eu\/docs\/EUCAN_AIM_Highlights.pdf (accessed January 2014)."},{"key":"BFnpjpcrm20149_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.7326\/0003-4819-151-2-200907210-00008","volume":"151","author":"V van der Meer","year":"2009","unstructured":"van der Meer V, Bakker MJ, van den Hout WB, Rabe KF, Sterk PJ, Kievit J et al. Internet-based self-management plus education compared with usual care in asthma: a randomized trial. Ann Intern Med 2009; 151: 110\u2013120.","journal-title":"Ann Intern Med"},{"key":"BFnpjpcrm20149_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","volume":"180","author":"HK Reddel","year":"2009","unstructured":"Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW et al. An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180: 59\u201399.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFnpjpcrm20149_CR28","first-page":"74","volume":"4","author":"D Price","year":"1999","unstructured":"Price D, Ryan D, Pearce L, Bride F . The AIR study: asthma in real life. Asthma J 1999; 4: 74\u201378.","journal-title":"Asthma J"},{"key":"BFnpjpcrm20149_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pcrj.2006.02.006","volume":"15","author":"M Moffat","year":"2006","unstructured":"Moffat M, Cleland J, van der Molen T, Price D . Sub-optimal patient and physician communication in primary care consultations: its relation to severe and difficult asthma. Prim Care Respir J 2006; 15: 159\u2013165.","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm20149_CR30","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.rmed.2008.08.003","volume":"102","author":"J Haughney","year":"2008","unstructured":"Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008; 102: 1681\u20131693.","journal-title":"Respir Med"},{"key":"BFnpjpcrm20149_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2466-7-8","volume":"7","author":"R Horne","year":"2007","unstructured":"Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007; 7: 8.","journal-title":"BMC Pulm Med"},{"key":"BFnpjpcrm20149_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1183\/09031936.02.00218402","volume":"19","author":"V Giraud","year":"2002","unstructured":"Giraud V, Roche N . Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19: 246\u2013251.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm20149_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta5260","volume":"5","author":"D Brocklebank","year":"2001","unstructured":"Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 2001; 5: 1\u2013149.","journal-title":"Health Technol Assess"},{"key":"BFnpjpcrm20149_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/jamp.2007.0634","volume":"21","author":"M Schulte","year":"2008","unstructured":"Schulte M, Osseiran K, Betz R, Wencker M, Brand P, Meyer T et al. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD. J Aerosol Med Pulm Drug Deliv 2008; 21: 321\u2013328.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"BFnpjpcrm20149_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4104\/pcrj.2010.00088","volume":"20","author":"A Hardwell","year":"2011","unstructured":"Hardwell A, Barber V, Hargadon T, McKnight E, Holmes J, Levy ML . Technique training does not improve the ability of most patients to use pressurised metered-dose inhalers (pMDIs). Prim Care Respir J 2011; 20: 92\u201396.","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm20149_CR36","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.rmed.2011.07.004","volume":"105","author":"V Giraud","year":"2011","unstructured":"Giraud V, Allaert FA, Roche N . Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med 2011; 105: 1815\u20131822.","journal-title":"Respir Med"},{"key":"BFnpjpcrm20149_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1378\/chest.105.1.111","volume":"105","author":"NA Hanania","year":"1994","unstructured":"Hanania NA, Wittman R, Kesten S, Chapman KR . Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994; 105: 111\u2013116.","journal-title":"Chest"},{"key":"BFnpjpcrm20149_CR38","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4104\/pcrj.2013.00091","volume":"22","author":"M Fletcher","year":"2013","unstructured":"Fletcher M, Hiles D . Continuing discrepancy between patient perception of asthma control and real-world symptoms: a quantitative online survey of 1,083 adults with asthma from the UK. Prim Care Respir J 2013; 22: 431\u2013438.","journal-title":"Prim Care Respir J"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm20149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm20149","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm20149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:01:02Z","timestamp":1672959662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm20149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,12]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,11,27]]}},"alternative-id":["BFnpjpcrm20149"],"URL":"https:\/\/doi.org\/10.1038\/npjpcrm.2014.9","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,12]]},"assertion":[{"value":"18 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DP has acted as a consultant and board member for Almirral, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Meda Pharma, Merck, Mundipharma, Napp, Novartis, Nycomed, Pfizer, Sandoz and Teva. He or his research team has received grants and support for research in respiratory disease from the following organisations in the past 5 years: Aerocrine, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Merck, Mundipharma, Novartis, Nycomed, Orion, Pfizer, Teva and the UK National Health Service. Grants\/grants pending: Aerocrine, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Merck, Mundipharma, Novartis, Nycomed, Orion, Pfizer, Takeda, Teva and the UK National Health Service. Payments for lectures\/speaking: Activaero, Almirral, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline, Kyorin, Novartis, Merck, Mundipharma, Pfizer, Takeda and Teva. Payment for manuscript preparation: Merck, Mundipharma and Teva. Stock\/stock options: shares in AKL Ltd, which produces phytopharmaceuticals; owner of 80% of Research in Real Life and its subsidiary social enterprise Optimum Patient Care. Payment for travel\/accommodation\/meeting expenses: Aerocrine, Boehringer Ingelheim, Mundipharma, Napp, Novartis and Teva. MF has received reimbursement for travel and accommodation from Amirall UK and Novartis AG. Education for Health received honoraria from Almirall, Boehringer, Ingelheim, Novartis AG and Novartis UK for advisory boards attended by MF. It also received educational grants from Almirall, Chiesi and TEVA, and grants for research in the last 5 years from Abbott Laboratories, AstraZeneca, Novartis AG, Pfizer and UCB. TvdM has acted as a consultant and board member for Almirral, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Mundipharma, Novartis and Teva, and as a consultant for MSD. Grants\/grants pending: His research department at the University of Groningen has received grants and support for research in respiratory disease from the following organisations in the past 5 years: AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Lung Foundation Netherlands, Merck, Mundipharma, Novartis, Nycomed and Stichting Astma Bestrijding. Payments for lectures\/speaking: Almirral, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline, Kyorin, Merck, Mundipharma, Novartis and Teva. Payment for travel\/accommodation\/meeting expenses: Boehringer Ingelheim, Mundipharma, Novartis and Teva.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14009"}}